SCHEMBL30766286

SCHEMBL30766286

COc1c(-c2ccc(O)c(O)c2)oc2cc(O)c(CC=C(C)C)c(O)c2c1=O

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.83
XDH P47989 1/20 0.69
MGAM O43451 4/20 0.66
GAA P10253 4/20 0.66
SI P14410 3/20 0.66
MGAM2 Q2M2H8 3/20 0.66
KDM4E B2RXH2 2/20 0.66
MEN1 O00255 2/20 0.66
MAPT P10636 2/20 0.66
KMT2A Q03164 2/20 0.66
HSD17B10 Q99714 2/20 0.66
PDE4D Q08499 2/20 0.66
SMPD1 P17405 2/20 0.66
IDH1 O75874 2/20 0.66
FASN P49327 2/20 0.66
RELA Q04206 2/20 0.66
SIRT2 Q8IXJ6 2/20 0.66
KDM1A O60341 1/20 0.66
USP2 O75604 1/20 0.66
ALDH1A1 P00352 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27006408 1.00 PTPN1 (0.83) PTPN1XDHMGAMGAASI
SCHEMBL6822762 0.92 PTPN1 (0.70) PTPN1XDHMGAMGAASI
SCHEMBL6822763 0.92 PTPN1 (0.70) PTPN1XDHMGAMGAASI
SCHEMBL12866240 0.91 PTPN1 (1.00) PTPN1XDHMGAMGAASI
SCHEMBL30266532 0.91 PTPN1 (1.00) PTPN1XDHMGAMGAASI
SCHEMBL26621023 0.90 PTPN1 (0.86) PTPN1XDHMGAMGAASI
Gancaonin P SCHEMBL1170933 0.88 MGAM (0.76) PTPN1XDHMGAMGAASI
SCHEMBL27013523 0.86 PDE5A (0.63) PTPN1XDHRELAKDM1ACYP19A1
SCHEMBL28370192 0.84 PDE5A (0.77) PTPN1GAAKDM4EMEN1MAPT
SCHEMBL30766198 0.84 XDH (0.69) PTPN1XDHMGAMGAASI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240016777-A1 COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS BETH ISRAEL DEACONESS MEDICAL CENTER, INC. 2024-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240016777-A1 COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS THPO, SERPINB1, SERPINC1 PTPN1 1318/4885XDH 240/4885MGAM 2440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.